Top Priorities for Life Science GBS Organizations in 2023: Scaling R&D Capabilities | Virtual Roundtable

Life Sciences GBS organizations today have evolved into strategic partners for their enterprises, driving both operational and technological advancements. As part of the evolution, Life Sciences GBS organizations are increasingly supporting critical functions, including R&D operations, and scaling up these capabilities has been a top priority.

Join this virtual roundtable as our experts and your peers discuss and explore the vision, effort, and support required for scaling R&D capabilities from offshore/nearshore delivery centers.

What you will take away:

In this collaborative session, we’ll uncover the key aspects of building R&D capabilities in GBS, such as:

• The vision for housing R&D capabilities in GBS and the value proposition of having an offshore/nearshore presence
• Key enablers and challenges in offshoring/nearshoring core capabilities
• Success driving actions from Life Sciences GBS leaders
• Success stories from best-in-class peers

Who should attend?

• GBS leaders
• GBS Strategy leaders
• GBS site leaders
• GBS R&D/Clinical leaders

Virtual Roundtable Guidelines

The only price of admission is participation. Attendees should be prepared to share their experiences and be willing to engage in discourse.

Participation is limited to enterprise leaders (no service providers). Everest Group will approve each attendance request to ensure an appropriate group size and mix of participants. The sessions are 90 minutes in duration and include introductions, a short presentation, and a facilitated discussion.